A detailed history of Moors & Cabot, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 14,758 shares of ZTS stock, worth $2.61 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
14,758
Previous 14,709 0.33%
Holding current value
$2.61 Million
Previous $2.55 Million 13.1%
% of portfolio
0.15%
Previous 0.14%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$172.58 - $196.48 $8,456 - $9,627
49 Added 0.33%
14,758 $2.88 Million
Q2 2024

Aug 09, 2024

BUY
$145.54 - $178.83 $36,967 - $45,422
254 Added 1.76%
14,709 $2.55 Million
Q1 2024

May 08, 2024

SELL
$165.67 - $199.94 $315,932 - $381,285
-1,907 Reduced 11.66%
14,455 $2.45 Million
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $9,843 - $13,005
-65 Reduced 0.4%
16,362 $3.23 Million
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $24,903 - $28,722
149 Added 0.92%
16,427 $2.86 Million
Q2 2023

Aug 09, 2023

BUY
$160.94 - $186.23 $53,432 - $61,828
332 Added 2.08%
16,278 $2.8 Million
Q1 2023

May 04, 2023

SELL
$145.48 - $175.02 $303,180 - $364,741
-2,084 Reduced 11.56%
15,946 $2.65 Million
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $54,947 - $65,979
-419 Reduced 2.27%
18,030 $2.64 Million
Q4 2022

Feb 06, 2023

BUY
$131.14 - $157.47 $84,454 - $101,410
644 Added 3.62%
18,449 $2.7 Million
Q3 2022

Nov 07, 2022

SELL
$148.29 - $182.55 $64,209 - $79,044
-433 Reduced 2.37%
17,805 $2.64 Million
Q2 2022

Aug 08, 2022

SELL
$155.97 - $200.09 $1,247 - $1,600
-8 Reduced 0.04%
18,238 $3.14 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $18,683 - $24,105
-103 Reduced 0.56%
18,246 $3.44 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $38,544 - $49,158
-199 Reduced 1.07%
18,349 $4.48 Million
Q3 2021

Dec 08, 2021

BUY
$189.29 - $209.69 $3.51 Million - $3.89 Million
18,548 New
18,548 $3.6 Million
Q3 2021

Nov 05, 2021

SELL
$189.29 - $209.69 $3.51 Million - $3.88 Million
-18,527 Closed
0 $0
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $53,161 - $64,104
341 Added 1.88%
18,527 $3.45 Million
Q1 2021

May 12, 2021

SELL
$144.0 - $169.39 $213,408 - $251,035
-1,482 Reduced 7.54%
18,186 $2.86 Million
Q4 2020

Feb 11, 2021

SELL
$157.07 - $174.35 $105,079 - $116,640
-669 Reduced 3.29%
19,668 $3.27 Million
Q3 2020

Nov 09, 2020

SELL
$137.1 - $165.37 $12,064 - $14,552
-88 Reduced 0.43%
20,337 $3.36 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $267,376 - $340,504
2,389 Added 13.25%
20,425 $2.8 Million
Q1 2020

May 12, 2020

SELL
$92.66 - $144.94 $611,556 - $956,604
-6,600 Reduced 26.79%
18,036 $2.13 Million
Q4 2019

Jan 28, 2020

SELL
$116.25 - $133.25 $13,136 - $15,057
-113 Reduced 0.46%
24,636 $3.26 Million
Q3 2019

Oct 22, 2019

BUY
$112.57 - $128.43 $767,389 - $875,507
6,817 Added 38.02%
24,749 $3.09 Million
Q2 2019

Jul 18, 2019

BUY
$97.98 - $114.28 $141,777 - $165,363
1,447 Added 8.78%
17,932 $2.03 Million
Q1 2019

May 06, 2019

SELL
$81.56 - $100.67 $1.34 Million - $1.66 Million
-16,485 Reduced 50.0%
16,485 $1.65 Million
Q1 2019

May 01, 2019

BUY
$81.56 - $100.67 $1.21 Million - $1.5 Million
14,890 Added 82.36%
32,970 $3.31 Million
Q4 2018

Feb 13, 2019

BUY
$79.28 - $95.27 $64,375 - $77,359
812 Added 4.7%
18,080 $1.55 Million
Q3 2018

Nov 14, 2018

SELL
$83.5 - $93.23 $106,379 - $118,775
-1,274 Reduced 6.87%
17,268 $1.58 Million
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $89,408 - $99,814
1,119 Added 6.42%
18,542 $1.59 Million
Q1 2018

May 18, 2018

BUY
$71.51 - $84.69 $112,699 - $133,471
1,576 Added 9.95%
17,423 $1.46 Million
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $11,256 - $12,958
178 Added 1.14%
15,847 $1.14 Million
Q3 2017

Nov 16, 2017

BUY
$59.73 - $65.4 $41,811 - $45,780
700 Added 4.68%
15,669 $1 Million
Q2 2017

Aug 15, 2017

BUY
N/A
14,969
14,969 $929,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.